Paradigm Biocapital Advisors LP - 31 Dec 2024 SCHEDULE 13G/A Report for Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (OLMA)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: OLMA
Shares outstanding: 74,367,918 shares
Disclosed Ownership: 7,429,355 shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:45:39 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	9.99%	7,429,355	7,429,355	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	9.99%	7,429,355	7,429,355	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	9.99%	7,429,355	7,429,355	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	9.1%	6,777,072	6,777,072	/s/ David K. Kim	David K. Kim / Authorized Signatory